More importantly, alterations in the sGC-cGMP-PKG pathway in HFpEF promote functional impairment in cardiomyocytes, as evidenced by delayed myocardial relaxation, increased myocardial stiffness, cardiac hypertrophy, and interstitial fibrosis (35). This evidence concerns the gene SGCB and cardiac hypertrophy.